Results 41 to 50 of about 406,493 (428)

Percutaneous coronary intervention

Medicine, 2002
Percutaneous coronary intervention (PCI) is the dominant method for mechanically improving myocardial perfusion in the treatment of coronary artery disease. The procedure is performed via a small intra-arterial sheath and usually involves a single overnight stay in hospital. Day-case treatment is not infrequent. A balloon is used to dilate the coronary
openaire   +4 more sources

Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk

European Heart Journal, 2019
Identification and management of patients at high bleeding risk undergoing percutaneous coronary intervention are of major importance, but a lack of standardization in defining this population limits trial design, data interpretation, and clinical ...
P. Urban, R. Mehran, R. Colleran, D. Angiolillo, R. Byrne, D. Capodanno, T. Cuisset, D. Cutlip, P. Eerdmans, J. Eikelboom, A. Farb, C. Gibson, J. Gregson, M. Haude, S. James, Hyo‐Soo Kim, Takeshi Kimura, A. Konishi, J. Laschinger, M. Leon, P. A. Magee, Yoshiaki Mitsutake, D. Mylotte, S. Pocock, M. Price, S. Rao, E. Spitzer, E. Spitzer, N. Stockbridge, M. Valgimigli, O. Varenne, Ute Windhoevel, R. Yeh, M. Krucoff, M. Krucoff, M. Morice   +35 more
semanticscholar   +1 more source

Facilitated Percutaneous Coronary Intervention

Journal of the American College of Cardiology, 2006
The goal of the initial treatment for ST-segment elevation myocardial infarction is rapid and effective reperfusion. Randomized trials have demonstrated that primary angioplasty is preferred over thrombolysis if done in a timely manner and by an experienced team. However, due to many factors, performance of primary angioplasty within the goal of 90 min
William Borden, David P. Faxon
openaire   +3 more sources

Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention.

Journal of the American Medical Association (JAMA), 2016
IMPORTANCE Dual antiplatelet therapy after percutaneous coronary intervention (PCI) reduces ischemia but increases bleeding. OBJECTIVE To develop a clinical decision tool to identify patients expected to derive benefit vs harm from continuing ...
R. Yeh, Eric A. Secemsky, D. Kereiakes, Sharon-Lise T Normand, A. Gershlick, David J Cohen, J. Spertus, P. Steg, D. Cutlip, M. Rinaldi, E. Camenzind, W. Wijns, Patricia Apruzzese, Yang Song, J. Massaro, L. Mauri   +15 more
semanticscholar   +1 more source

Impact of COVID-19 on percutaneous coronary intervention for ST-elevation myocardial infarction

Heart, 2020
Background The objective of the study was to identify any changes in primary percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI) in England by analysing procedural numbers, clinical characteristics and patient outcomes
C. Kwok, C. Gale, T. Kinnaird, N. Curzen, P. Ludman, E. Kontopantelis, Jianhua Wu, T. Denwood, N. Fazal, J. Deanfield, M. de Belder, M. Mamas   +11 more
semanticscholar   +1 more source

Timing of AKI after urgent percutaneous coronary intervention and clinical outcomes: a high-dimensional propensity score analysis

BMC Nephrology, 2021
Introduction Acute kidney injury is a common complication of percutaneous coronary intervention and has been associated with an increased risk of death and progressive chronic kidney disease.
Alan S. Go, Thida C. Tan, Rishi V. Parikh, Andrew P. Ambrosy, Leonid V. Pravoverov, Sijie Zheng, Thomas K. Leong   +6 more
doaj   +1 more source

Dynamic Coronary Roadmapping via Catheter Tip Tracking in X-ray Fluoroscopy with Deep Learning Based Bayesian Filtering [PDF]

, 2020
Percutaneous coronary intervention (PCI) is typically performed with image guidance using X-ray angiograms in which coronary arteries are opacified with X-ray opaque contrast agents. Interventional cardiologists typically navigate instruments using non-contrast-enhanced fluoroscopic images, since higher use of contrast agents increases the risk of ...
arxiv   +1 more source

Effect of P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy on Cardiovascular Events in Patients Undergoing Percutaneous Coronary Intervention: The SMART-CHOICE Randomized Clinical Trial.

Journal of the American Medical Association (JAMA), 2019
Importance Data on P2Y12 inhibitor monotherapy after short-duration dual antiplatelet therapy (DAPT) in patients undergoing percutaneous coronary intervention are limited.
J. Hahn, Y. Song, J. Oh, W. Chun, Yong Hwan Park, W. Jang, E. Im, J. Jeong, B. Cho, S. Oh, K. Yun, D. Cho, Jong-Young Lee, Young‐Youp Koh, J. Bae, Jaewoong Choi, Wang-Soo Lee, H. Yoon, S. U. Lee, Jang-hyun Cho, W. Choi, S. Rha, J. Lee, T. Park, Jeong Hoon Yang, Jin‐Ho Choi, S. Choi, Sang Hoon Lee, H. Gwon   +28 more
semanticscholar   +1 more source

Risk/Benefit Tradeoff of Antithrombotic Therapy in Patients With Atrial Fibrillation Early and Late After an Acute Coronary Syndrome or Percutaneous Coronary Intervention

Circulation, 2020
Background: In AUGUSTUS (Open-Label, 2×2 Factorial, Randomized, Controlled Clinical Trial to Evaluate the Safety of Apixaban vs Vitamin K Antagonist and Aspirin vs Aspirin Placebo in Patients With Atrial Fibrillation and Acute Coronary Syndrome and/or ...
J. Alexander, D. Wojdyla, A. Vora, L. Thomas, C. Granger, S. Goodman, R. Aronson, S. Windecker, R. Mehran, R. Lopes   +9 more
semanticscholar   +1 more source

Editöre Mektup - Red cell distribution width and contrast-induced nephropathy in patients who underwent primary percutaneous coronary intervention

Türk Kardiyoloji Derneği Arşivi, 2016
red cell distribution width and contrast-induced nephropathy in patients underwent primary percutaneous coronary intervention red cell distribution width and contrast-induced nephropathy in patients underwent primary percutaneous coronary intervention ...
Somsri Wiwanitkit, Viroj Wiwanitkit
doaj   +1 more source